,IMGT entry ID,IMGT molecule name,Species,IMGT entry type,IMGT receptor description,Ligand(s),Experimental technique,Resolution,PDB releaseÂ date,,2.6,17-SEP-97
1,1ao7,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Tax peptide 11-19 (Q82235) (Peptide),X-ray diffraction,2.6,17-SEP-97,2.5,19-AUG-98,
2,1bd2,MH1 HLA-A*0201; TR B7,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Tax peptide 11-19 (Q82235) (Peptide),X-ray diffraction,2.5,19-AUG-98,2.5,24-FEB-09,
3,1fo0,MH1-K1b (H2-K1b); TR BM3.3,Mus musculus,PDB,MH1-ALPHA_B2M; FV-ALPHA_BETA,pBM1 peptide (Peptide),X-ray diffraction,2.5,24-FEB-09,2.8,24-FEB-09,
4,1g6r,MH1-K1b (H2-K1b); TR 2C,Mus musculus,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Superantagonist peptide SIYR (Peptide),X-ray diffraction,2.8,24-FEB-09,2.4,15-MAY-02,
5,1jtr,MH1-K1b (H2-K1b); TR 2C,Mus musculus,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,NADH-ubiquinone oxidoreductase MLRQ subunit peptide 61-68 (Q62425) (Peptide),X-ray diffraction,2.4,15-MAY-02,2.71,13-JUL-11,
6,1kj2,MH1-K1b (H2-K1b); TR KB5-C20,Mus musculus,PDB,MH1-ALPHA_B2M; FV-ALPHA_BETA,GTP-binding protein 1 peptide 161-168 pKB1 (O08582) (Peptide),X-ray diffraction,2.71,13-JUL-11,2,13-JUL-11,
7,1lp9,MH1 HLA-A*0201; TR 12.2,"Mus musculus, Homo sapiens",PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Self peptide P1049 (Peptide),X-ray diffraction,2,13-JUL-11,2.5,24-FEB-09,
8,1mi5,MH1 HLA-B*0801; TR LC13,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"EBNA-3A peptide 193-201 (P12977), I9>L (Peptide)",X-ray diffraction,2.5,24-FEB-09,2.4,13-JUL-11,
9,1mwa,MH1-K1b (H2-K1b); TR 2C,Mus musculus,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,NADH-ubiquinone oxidoreductase MLRQ subunit peptide 61-68 (Q62425) (Peptide),X-ray diffraction,2.4,13-JUL-11,2.7,13-JUL-11,
10,1nam,MH1-K1b (H2-K1b); TR BM3.3,Mus musculus,PDB,MH1-ALPHA_B2M; FV-ALPHA_BETA,Nucleocapsid protein VSV8 peptide 52-59 (P11212) (Peptide),X-ray diffraction,2.7,13-JUL-11,2.8,24-FEB-09,
11,1qrn,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"Tax peptide 11-19 (Q82235), P6>A (Peptide)",X-ray diffraction,2.8,24-FEB-09,2.8,25-AUG-09,
12,1qse,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"Tax peptide 11-19 (Q82235), V7>R (Peptide)",X-ray diffraction,2.8,25-AUG-09,2.8,25-AUG-09,
13,1qsf,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"Tax peptide 11-19 (Q82235), Y8>A (Peptide)",X-ray diffraction,2.8,25-AUG-09,3.4,13-JUL-11,
14,1ypz,MH1 H2-T22; TR G8,"Mus musculus, Homo sapiens",PDB,MH1-ALPHA_B2M; TR-GAMMA-1_DELTA,,X-ray diffraction,3.4,13-JUL-11,2.5,24-FEB-09,
15,2ak4,MH1 HLA-B*3508; TR SB27,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,BZLF1 trans-activator protein peptide 52-64 (P03206) (Peptide),X-ray diffraction,2.5,24-FEB-09,1.7,24-FEB-09,
16,2bnq,MH1 HLA-A*0201; TR 1G4,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"NY-ESO-1 tumor-associated antigen, C9>V (Peptide)",X-ray diffraction,1.7,24-FEB-09,1.9,24-FEB-09,
17,2bnr,MH1 HLA-A*0201; TR 1G4,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,NY-ESO-1 tumor-associated antigen (Peptide),X-ray diffraction,1.9,24-FEB-09,3,24-FEB-09,
18,2ckb,MH1-K1b (H2-K1b); TR 2C,Mus musculus,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,NADH-ubiquinone oxidoreductase MLRQ subunit peptide 61-68 (Q62425) (Peptide),X-ray diffraction,3,24-FEB-09,2.5,27-JUL-11,
19,2e7l,MH1 H2-Ld-2; TR 2C,Mus musculus,PDB,(G-ALPHA1-ALPHA2); FV-ALPHA_BETA,Peptide (GLN)(LEU)(SER)(PRO)(PHE)(PRO)(PHE)(ASP)(LEU) (Peptide),X-ray diffraction,2.5,27-JUL-11,2.6,24-FEB-09,
20,2esv,MH1 HLA-E*0101; TR KK50.4,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Peptide from CMV gpUL40 (Peptide),X-ray diffraction,2.6,24-FEB-09,2.1,13-JUL-11,
21,2f53,MH1 HLA-A*0201; TR 1G4 mutant (c49c50 ),Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,NY-ESO-1 tumor-associated antigen (Peptide),X-ray diffraction,2.1,13-JUL-11,2.7,13-JUL-11,
22,2f54,MH1 HLA-A*0201; TR 1G4 (AV-wt),Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,NY-ESO-1 tumor-associated antigen (Peptide),X-ray diffraction,2.7,13-JUL-11,2.56,13-JUL-11,
23,2gj6,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"HTLV-1 TAX peptide, Y5>K-IBA (Protein)",X-ray diffraction,2.56,13-JUL-11,03-AUG-11,,
24,2j8u,"MH1 HLA-A*0201, K66>A; TR AHIII","Homo sapiens, Mus musculus",PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Self peptide P1049 (from C15ORF24 uncharacterized protein) (Peptide),X-ray diffraction,2.88,03-AUG-11,24-FEB-09,,
25,2jcc,"MH1 HLA-A*0201, W167>A; TR AHIII","Homo sapiens, Mus musculus",PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Self peptide P1049 (from C15ORF24 uncharacterized protein) (Peptide),X-ray diffraction,2.5,24-FEB-09,2.7,28-APR-10,
26,2nx5,MH1 HLA-B*3501; TR ELS4,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,EBV peptide (Peptide),X-ray diffraction,2.7,28-APR-10,24-FEB-09,,
27,2oi9,"MH1 H2-Ld-2, F9>Y, V12>T, I23>T; TR",Mus musculus,PDB,(G-ALPHA1-ALPHA2); FV-ALPHA_BETA,Peptide (GLN)(LEU)(SER)(PRO)(PHE)(PRO)(PHE)(ASP) (Peptide),X-ray diffraction,2.35,24-FEB-09,2.9,13-JUL-11,
28,2ol3,MH1-K1b (H2-K1b); TR BM3.3,Mus musculus,PDB,MH1-ALPHA_B2M; FV-ALPHA_BETA,Octapeptide PBM8 (Peptide),X-ray diffraction,2.9,13-JUL-11,1.89,13-JUL-11,
29,2p5e,MH1 HLA-A*0201; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Cancer/testis antigen 1B peptide 157-165 (P78358) (Peptide),X-ray diffraction,1.89,13-JUL-11,2.2,13-JUL-11,
30,2p5w,MH1 HLA-A*0201; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Cancer/testis antigen 1B peptide 157-165 (P78358) (Peptide),X-ray diffraction,2.2,13-JUL-11,2.3,13-JUL-11,
31,2pye,MH1 HLA-A*0201; TR C5C1,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Cancer/testis antigen 1B peptide 157-165 (P78358) (Peptide),X-ray diffraction,2.3,13-JUL-11,13-JUL-11,,
32,2uwe,"MH1 HLA-A*0201, T163A; TR AHIII","Homo sapiens, Mus musculus",PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Self peptide P1049 (from C15ORF24 uncharacterized protein) (Peptide),X-ray diffraction,2.4,13-JUL-11,2.4,13-JUL-11,
33,2vlj,MH1 HLA-A*0201; TR JM22,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Influenza matrix peptide (58-66) (Peptide),X-ray diffraction,2.4,13-JUL-11,2.5,13-JUL-11,
34,2vlk,MH1 HLA-A*0201; TR JM22,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Influenza matrix peptide (58-66) (Peptide),X-ray diffraction,2.5,13-JUL-11,2.3,13-JUL-11,
35,2vlr,MH1 HLA-A*0201; TR JM22,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Influenza matrix peptide (58-66) (Peptide),X-ray diffraction,2.3,13-JUL-11,2.4,28-NOV-12,
36,2ypl,MH1 HLA B-57; TR AGA,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,KF11 P24 GAG PEPTIDE (Peptide),X-ray diffraction,2.4,28-NOV-12,30-MAR-11,,
37,3ard,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,3.01,30-MAR-11,2.81,13-JUL-11,
38,3d39,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Modified HTLV-1 TAX (Y5(4-fluoroPhenylalanine)) peptide (Peptide),X-ray diffraction,2.81,13-JUL-11,2.8,13-JUL-11,
39,3d3v,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Modified HTLV-1 TAX (Y5(4-fluoroPhenylalanine)) peptide (Peptide),X-ray diffraction,2.8,13-JUL-11,3.5,13-JUL-11,
40,3dxa,MH1 HLA-B*4405; TR DM1,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,EBV decapeptide epitope 281-290 (Peptide),X-ray diffraction,3.5,13-JUL-11,3.8,24-FEB-09,
41,3e2h,MH1 H2-Ld-2; TR V(alpha)PHDS58 - V(beta)M67,Mus musculus,PDB,(G-ALPHA1-ALPHA2); FV-ALPHA_BETA,QL9 peptide (Peptide),X-ray diffraction,3.8,24-FEB-09,2.8,04-AUG-09,
42,3gsn,MH1 HLA-A*0201; TR RA14,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,HCMV pp65 fragment 495-503 (Peptide),X-ray diffraction,2.8,04-AUG-09,2.7,13-JUL-11,
43,3h9s,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Tel1p peptide (Peptide),X-ray diffraction,2.7,13-JUL-11,13-JUL-11,,
44,3he6,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.9,13-JUL-11,3,13-JUL-11,
45,3hg1,MH1 HLA-A*0201; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,MART-1 (Melan-A) (Peptide),X-ray diffraction,3,13-JUL-11,2.6,21-APR-10,
46,3kpr,MH1 HLA-B*4405; TR LC13,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Mimotope peptide (Peptide),X-ray diffraction,2.6,21-APR-10,2.7,21-APR-10,
47,3kps,MH1 HLA-B*4405; TR LC13,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Self peptide from the ATP binding cassette protein ABCD3 (Peptide),X-ray diffraction,2.7,21-APR-10,27-APR-11,,
48,3kxf,"MH1 HLA-B*3508, Q65>A, T69>A, Q155>A; TR SB27",Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Peptide from Trans-activator protein BZLF1 (Peptide),X-ray diffraction,3.1,27-APR-11,2,20-JUL-11,
49,3mv7,MH1 HLA-B*3501; TR TK3,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,HPVG peptide from Epstein-Barr nuclear antigen 1 (Peptide),X-ray diffraction,2,20-JUL-11,2.1,20-JUL-11,
50,3mv8,MH1 HLA-B*3501; TR TK3,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,HPVG peptide from Epstein-Barr nuclear antigen 1 (Peptide),X-ray diffraction,2.1,20-JUL-11,20-JUL-11,,
51,3mv9,"MH1 HLA-B*3501; TR TK3, Q>55A",Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,HPVG peptide from Epstein-Barr nuclear antigen 1 (Peptide),X-ray diffraction,2.7,20-JUL-11,2.68,29-JUN-11,
52,3nfj,MH1 HLA-A*2402; TR Beta_V-delta-C-alpha,Homo sapiens,PDB,MH1-ALPHA_B2M; (TR-BETA-1_V-DELTA-C-ALPHA),10-mer peptide from Protein Nef (Q9YYU8) (Peptide),X-ray diffraction,2.68,29-JUN-11,2.54,12-JAN-11,
53,3o4l,MH1 HLA-A*0201; TR AS01,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,BSLF2/BMLF1 peptide (Peptide),X-ray diffraction,2.54,12-JAN-11,13-OCT-10,,
54,3o8x,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.74,13-OCT-10,3.19,18-MAY-11,
55,3pqy,MH1-D1b (H2-D1b); TR 6218,"Mus musculus, Homo sapiens",PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,10-mer peptide from RNA-directed RNA polymerase (Peptide),X-ray diffraction,3.19,18-MAY-11,2.69,09-MAR-11,
56,3pwp,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,HuD peptide (Peptide),X-ray diffraction,2.69,09-MAR-11,2.69,07-SEP-11,
57,3qdg,MH1 HLA-A*0201; TR DMF5,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,"Mart-1 (26-35) peptide, A27>L (Peptide)",X-ray diffraction,2.69,07-SEP-11,2.3,07-SEP-11,
58,3qdj,MH1 HLA-A*0201; TR DMF5,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Mart-1 (27-35) peptide (Peptide),X-ray diffraction,2.3,07-SEP-11,2.8,07-SEP-11,
59,3qdm,MH1 HLA-A*0201; TR DMF4,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,"Mart-1 (27-35) peptide, A27>L (Peptide)",X-ray diffraction,2.8,07-SEP-11,2.59,07-SEP-11,
60,3qeq,MH1 HLA-A*0201; TR DMF4,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Mart-1 (27-35) peptide (Peptide),X-ray diffraction,2.59,07-SEP-11,2.29,11-JAN-12,
61,3qfj,MH1 HLA-A*0201; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"Tax peptide 11-19 (Q82235), Y5>F [HTLV1] (Peptide)",X-ray diffraction,2.29,11-JAN-12,29-JUN-11,,
62,3quy,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.25,29-JUN-11,29-JUN-11,,
63,3quz,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Mus musculus, Chimeric",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.3,29-JUN-11,03-AUG-11,,
64,3rgv,"MH1-K1b (H2-K1b); TR YAE62, Y84>C, C121>S","Chimeric, Mus musculus",PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,13-mer peptide (Peptide),X-ray diffraction,2.9,03-AUG-11,18-APR-12,,
65,3rtq,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.8,18-APR-12,03-AUG-11,,
66,3rug,"CD1D1; TR TRAV13D-3*01-TRAJ50*01, TRBV13-3*01 semi-invariant","Mus musculus, Chimeric",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.2,03-AUG-11,07-SEP-11,,
67,3rzc,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Mus musculus, Chimeric",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.8,07-SEP-11,05-OCT-11,,
68,3sda,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV19*01","Mus musculus, Chimeric",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.8,05-OCT-11,05-OCT-11,,
69,3sdc,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV19*01","Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,3.1,05-OCT-11,3.1,01-AUG-12,
70,3sjv,MH1 HLA-B*0801; TR RL42,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Epstein-Barr nuclear antigen 3 (Peptide),X-ray diffraction,3.1,01-AUG-12,23-NOV-11,,
71,3ta3,"CD1D1; TR TRAV11*02-TRAJ18*01, TRBV13-2*01","Mus musculus, Chimeric",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.7,23-NOV-11,2.75,18-JAN-12,
72,3tf7,MH1 H2-Ld SBM2; TR scFv 42F3 Mut7,Mus musculus,PDB,(G-ALPHA1-ALPHA2); SCFV-ALPHA-BETA,QL9 peptide (QLSPFPFDL) (Peptide),X-ray diffraction,2.75,18-JAN-12,2.75,18-JAN-12,
73,3tfk,MH1 H2-Ld SBM2; TR 42F3,"Chimeric, Mus musculus",PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,p4B10 peptide (Peptide),X-ray diffraction,2.75,18-JAN-12,2.12,18-JAN-12,
74,3tjh,MH1 H2-Ld SBM2; TR 42F3,"Homo sapiens, Mus musculus",PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,p3A1 (Peptide),X-ray diffraction,2.12,18-JAN-12,3.1,18-JAN-12,
75,3tpu,MH1 H2-Ld SBM2; TR 42F3,"Mus musculus, Chimeric",PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,p5E8 peptide (Peptide),X-ray diffraction,3.1,18-JAN-12,07-MAR-12,,
76,3uts,"MH1 HLA-A*0201; TR 1E6, autoreactive",Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"insulin peptide signal (15-24, P01308) (Peptide)",X-ray diffraction,2.71,07-MAR-12,07-MAR-12,,
77,3utt,"MH1 HLA-A*0201; TR 1E6, autoreactive",Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,"insulin peptide signal (15-24, P01308) (Peptide)",X-ray diffraction,2.6,07-MAR-12,17-OCT-12,,
78,3vwk,"CD1D; TR NKT15 TRAV10*01-TRAJ18*01, TRBV25-1*01 semi-invariant",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.94,17-OCT-12,2.5,23-OCT-13,
79,3vxm,MH1 HLA-A*2402; TR C1-28,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,10-mer peptide from Protein Nef KK10 263-272 (Peptide),X-ray diffraction,2.5,23-OCT-13,2.4,23-OCT-13,
80,3vxr,MH1 HLA-A*2402; TR H27-14,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,10-mer peptide from Protein Nef KK10 263-272 (Peptide),X-ray diffraction,2.4,23-OCT-13,1.8,23-OCT-13,
81,3vxs,MH1 HLA-A*2402; TR H27-14,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,10-mer peptide from Protein Nef KK10 263-272 (Peptide),X-ray diffraction,1.8,23-OCT-13,X-ray diffraction,2.7,23-OCT-13
82,3vxu,MH1 HLA-A*2402; TR T36-5; TR T36-5 TCR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,10-mer peptide from Protein Nef KK10 263-272 (Peptide),X-ray diffraction,2.7,23-OCT-13,2.6,06-NOV-13,
83,3w0w,MH1 HLA-A*2402; TR T36-5,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,10-mer peptide from Protein Nef KK10 263-272 (Peptide),X-ray diffraction,2.6,06-NOV-13,2.88,01-MAY-13,
84,4eup,MH1 HLA-A; TR JKF6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Melanoma antigen 1 KK10 263-272 (Peptide),X-ray diffraction,2.88,01-MAY-13,2.69,01-MAY-13,
85,4euq,MH1 HLA-A; TR JKF6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Melanoma antigen 1 KK10 263-272 (Peptide),X-ray diffraction,2.69,01-MAY-13,2.74,03-JUL-13,
86,4ftv,MH1 HLA-A2; TR A6,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,PROTEIN TAX-1 (Peptide),X-ray diffraction,2.74,03-JUL-13,2.4,20-MAR-13,
87,4g8g,MH1 HLA-B*2705; TR C12C,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,P24 (Peptide),X-ray diffraction,2.4,20-MAR-13,1.9,20-MAR-13,
88,4g9f,MH1 HLA-B*2705; TR C12C,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Gag protein epitope mame KK10 263-272 (L268>M) (Peptide),X-ray diffraction,1.9,20-MAR-13,2.46,29-MAY-13,
89,4jfd,MH1 HLA-A; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Melanoma peptide (Peptide),X-ray diffraction,2.46,29-MAY-13,2.7,29-MAY-13,
90,4jfe,MH1 HLA-A; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Melanoma peptide L7A (Peptide),X-ray diffraction,2.7,29-MAY-13,2.43,29-MAY-13,
91,4jff,MH1 HLA-A; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Melanoma peptide (Peptide),X-ray diffraction,2.43,29-MAY-13,2.3,10-APR-13,
92,4jrx,MH1 HLA-B*3505; TR CA5,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Trans-activator protein BZLF1 (Peptide),X-ray diffraction,2.3,10-APR-13,2.8,10-APR-13,
93,4jry,MH1 HLA-B*3505; TR SB47,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Trans-activator protein BZLF1 (Peptide),X-ray diffraction,2.8,10-APR-13,2.56,11-JUN-14,
94,4l3e,MH1 HLA-A; TR DMF5,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Melanoma antigen 1 (Peptide),X-ray diffraction,2.56,11-JUN-14,17-JUL-13,,
95,4l4v,"MR1; TR MAIT TRAV1-2*01-TRAJ33*01, TRBV6-1*01",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,1.9,17-JUL-13,2.99,28-MAY-14,
96,4mji,MH1 HLA-B*5101; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,HIV Reverse Transcriptase peptide Marker (Peptide),X-ray diffraction,2.99,28-MAY-14,2.74,13-NOV-13,
97,4mnq,MH1 HLA-A; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,Telomerase reverse transcriptase (Peptide),X-ray diffraction,2.74,13-NOV-13,1.92,24-SEP-14,
98,4ms8,42F3; H-2Ld,"Chimeric, Mus musculus",PDB,TR-ALPHA_BETA-2; (G-ALPHA1-ALPHA2),pCPB9 (Peptide),X-ray diffraction,1.92,24-SEP-14,3.09,19-AUG-15,
99,4mvb,MH1 H-2Ld; TR 42F3,Mus musculus,PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,PCPB7 (Peptide),X-ray diffraction,3.09,19-AUG-15,2.6,19-AUG-15,
100,4mxq,MH1 H-2Ld; TR 42F3,Mus musculus,PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,PCPC5 (Peptide),X-ray diffraction,2.6,19-AUG-15,2.9,19-AUG-15,
101,4n0c,MH1 H-2Ld; TR 42F3,Mus musculus,PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,PCPE3 (Peptide),X-ray diffraction,2.9,19-AUG-15,3.06,19-AUG-15,
102,4n5e,MH1 H-2Ld; TR 42F3,Mus musculus,PDB,(G-ALPHA1-ALPHA2); TR-ALPHA_BETA-2,PCPA12 (Peptide),X-ray diffraction,3.06,19-AUG-15,02-JUL-14,,
103,4pja,"MR1; TR MAIT TRAV1-2*01-TRAJ33*01, TRBV6-1*01",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.68,02-JUL-14,09-JUL-14,,
104,4pjf,"MR1; TR MAIT TRAV1-2*01-TRAJ33*01, TRBV6-1*01",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.45,09-JUL-14,02-JUL-14,,
105,4pjg,"MR1; TR MAIT TRAV1-2*01-TRAJ33*01, TRBV6-1*01",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.4,02-JUL-14,2.5,30-APR-14,
106,4prh,MH1 HLA-B*3508; TR TK3,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Epstein-Barr nuclear antigen 1 (Peptide),X-ray diffraction,2.5,30-APR-14,2.4,16-APR-14,
107,4pri,MH1 HLA-B*3508; TR TK3,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Epstein-Barr nuclear antigen 1 (Peptide),X-ray diffraction,2.4,16-APR-14,2.5,16-APR-14,
108,4prp,MH1 HLA-B*3501; TR TK3,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Epstein-Barr nuclear antigen 1 (Peptide),X-ray diffraction,2.5,16-APR-14,3,17-DEC-14,
109,4qok,MH1 HLA-A*02; TR MEL5,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,Melanoma antigen recognized by T-cells 1 marker peptide (Peptide),X-ray diffraction,3,17-DEC-14,2.9,12-NOV-14,
110,4qrp,MH1 HLA-B*0801; TR DD31,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,NS3-4A protein (Peptide),X-ray diffraction,2.9,12-NOV-14,2.5,26-NOV-14,
111,4wo4,CD1D; TR TRDV1*01_TRVB20*01 C13>S,Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; (TR-BETA-2_V-DELTA-C-ALPHA),,X-ray diffraction,2.5,26-NOV-14,2.6,03-JUN-15,
112,4y16,CD1D1; TR Valpha14/Jalpha18,"Chimeric, Mus musculus",PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.6,03-JUN-15,2.4,27-APR-16,
113,4zez,HCV 1406 TR; MH1 HLA-A,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,HCV NS3 peptide residues1406-1415 (Peptide),X-ray diffraction,2.4,27-APR-16,2.62,02-MAR-16,
114,5brz,MH1 HLA-A1; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,GLU-VAL-ASP-PRO-ILE-GLY-HIS-LEU-TYR (Peptide),X-ray diffraction,2.62,02-MAR-16,2.4,02-MAR-16,
115,5bs0,MH1 HLA-A1; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,TITIN (Peptide),X-ray diffraction,2.4,02-MAR-16,2.11,04-MAY-16,
116,5c07,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,Marker peptide (Peptide),X-ray diffraction,2.11,04-MAY-16,2.33,04-MAY-16,
117,5c08,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,Marker peptide (Peptide),X-ray diffraction,2.33,04-MAY-16,2.48,04-MAY-16,
118,5c09,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,Marker peptide (Peptide),X-ray diffraction,2.48,04-MAY-16,2.46,04-MAY-16,
119,5c0a,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,Marker peptide (Peptide),X-ray diffraction,2.46,04-MAY-16,2.03,04-MAY-16,
120,5c0b,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,Marker peptide (Peptide),X-ray diffraction,2.03,04-MAY-16,1.97,04-MAY-16,
121,5c0c,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,Marker peptide (Peptide),X-ray diffraction,1.97,04-MAY-16,07-OCT-15,,
122,5d2n,"MH1 HLA-A2; TR C25 TRAV26-2*01-TRAJ43*01, TRBV7-6*01",Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-1,ASN-LEU-VAL-PRO-MET-VAL-ALA-THR-VAL (Peptide),X-ray diffraction,2.1,07-OCT-15,27-JAN-16,,
123,5d5m,"MR1; TR MAIT TRAV1-2*01-TRAJ33*01, TRBV6-4*01",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,2.2,27-JAN-16,27-JAN-16,,
124,5d7j,"MR1; TR MAIT TRAV1-2*01-TRAJ33*01, TRBV6-4*01",Homo sapiens,PDB,MH1LIKE-ALPHA-LIKE_B2M; TR-ALPHA_BETA-2,,X-ray diffraction,1.97,27-JAN-16,3.4,27-JAN-16,
125,5d7l,MAV36 TR; MR1,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1LIKE-ALPHA-LIKE_B2M,,X-ray diffraction,3.4,27-JAN-16,2.51,08-JUN-16,
126,5e9d,A6 TR; HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA; MH1-ALPHA_B2M,Melanoma derived Mart-1 peptide (Peptide),X-ray diffraction,2.51,08-JUN-16,2.02,02-MAR-16,
127,5eu6,MH1 HLA-A2; TR,Homo sapiens,PDB,MH1-ALPHA_B2M; TR-ALPHA_BETA-2,TYR-LEU-GLU-PRO-GLY-PRO-VAL-THR-VAL (Peptide),X-ray diffraction,2.02,02-MAR-16,2.5,23-MAR-16,
128,5hhm,JM22 TR; MH1 HLA-A*0201,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,"M1-F5L, GILGLVFTL (Peptide)",X-ray diffraction,2.5,23-MAR-16,2.95,23-MAR-16,
129,5hho,JM22 TR; MH1 HLA-A*0201,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,"M1-G4E, GILEFVFTL (Peptide)",X-ray diffraction,2.95,23-MAR-16,3.06,04-MAY-16,
130,5hyj,1E6 TR; MH1 HLA-A2,Homo sapiens,PDB,TR-ALPHA_BETA-2; MH1-ALPHA_B2M,ALA-GLN-TRP-GLY-PRO-ASP-PRO-ALA-ALA-ALA (Peptide),X-ray diffraction,3.06,04-MAY-16,,,
